Fig. 6From: Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse modelsCultured osteoclast and osteoblasts respond to MRS7216 treatment. a,b Representative images and quantification of differentiated osteoclast in response to different treatment doses. **p<0.05 vs AlenP and alendronate. c,d Representative images and quantification of the calcification on the osteoblast cultures in response to different treatments. * p<0.05 vs Control, # p<0.05 vs MRS7216+ZM, & p<0.05 vs AlenPBack to article page